Advertisement

Topics

Plans unveiled to rid FDA of orphan designation backlog

08:06 EDT 30 Jun 2017 | EPM Magazine

The US Food and Drug Administration (FDA) has revealed its strategic plan to eliminate its orphan designation request backlog and to ensure there is continued timely response to new requests.

Original Article: Plans unveiled to rid FDA of orphan designation backlog

NEXT ARTICLE

More From BioPortfolio on "Plans unveiled to rid FDA of orphan designation backlog"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...